BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38522933)

  • 21. Diffuse cutaneous mastocytosis masquerading as epidermolysis bullosa.
    Kleewein K; Lang R; Diem A; Vogel T; Pohla-Gubo G; Bauer JW; Hintner H; Laimer M
    Pediatr Dermatol; 2011; 28(6):720-725. PubMed ID: 21854415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous mastocytosis in children: a clinical analysis of 71 cases.
    Kiszewski AE; Durán-Mckinster C; Orozco-Covarrubias L; Gutiérrez-Castrellón P; Ruiz-Maldonado R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):285-90. PubMed ID: 15096137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.
    Agarwala MK; George R; Mathews V; Balasubramanian P; Thomas M; Nair S
    J Dermatolog Treat; 2013 Dec; 24(6):481-3. PubMed ID: 23659595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis.
    Barnes M; Van L; DeLong L; Lawley LP
    Pediatr Dermatol; 2014; 31(3):271-5. PubMed ID: 24612340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype and phenotype analysis of patients with pediatric cutaneous mastocytosis, especially wild-type KIT patients.
    Arase N; Wataya-Kaneda M; Murota H; Nakagawa Y; Yamaoka T; Itoi-Ochi S; Hirayasu K; Arase H; Fujimoto M; Katayama I
    J Dermatol; 2020 Apr; 47(4):426-429. PubMed ID: 32077120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mastocytosis in children].
    Wassmer H; Hartmann K
    Dermatologie (Heidelb); 2023 May; 74(5):323-329. PubMed ID: 37140636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel R634W c-kit mutation identified in familial mastocytosis.
    Pollard WL; Beachkofsky TM; Kobayashi TT
    Pediatr Dermatol; 2015; 32(2):267-70. PubMed ID: 25243845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical observations in cutan mastocytosis].
    Mihalik N; Hidvégi B; Hársing J; Várkonyi J; Csomor J; Kovalszky I; Marschalkó M; Kárpáti S
    Orv Hetil; 2013 Sep; 154(37):1469-75. PubMed ID: 24016753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new variant of mastocytosis: report of three cases clinicopathologically mimicking histiocytic and vasculitic disorders.
    Dunst KM; Huemer GM; Zelger BG; Zelger B
    Br J Dermatol; 2005 Sep; 153(3):642-6. PubMed ID: 16120157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients.
    Akoglu G; Erkin G; Cakir B; Boztepe G; Sahin S; Karaduman A; Atakan N; Akan T; Kolemen F
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):969-73. PubMed ID: 16922947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations.
    Fett NM; Teng J; Longley BJ
    Am J Dermatopathol; 2013 Feb; 35(1):113-6. PubMed ID: 22892471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient.
    Patel K; Cuervo-Pardo L; Cresoe S; Cavero-Chavez V
    Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):150-152. PubMed ID: 38134319
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinicopathological Profile of Childhood Onset Cutaneous Mastocytosis from a Tertiary Care Center in South India.
    Sathishkumar D; Balasundaram A; Mathew SM; Mathew L; Thomas M; Balasubramanian P; George R
    Indian Dermatol Online J; 2021; 12(5):706-713. PubMed ID: 34667757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cutaneous mastocytosis with onset in children and adults.
    Güneş Bilgili S; Karadağ AS; Takci Z; Çalka Ö; Kösem M
    Turk J Med Sci; 2014; 44(3):504-10. PubMed ID: 25558657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
    Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
    Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatoscopy of Urticaria Pigmentosa with and without Darier's Sign in Skin of Colour.
    Nirmal B; Krishnaram AS; Muthu Y; Rajagopal P
    Indian Dermatol Online J; 2019; 10(5):577-579. PubMed ID: 31544081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urticaria pigmentosa and systemic mastocytosis.
    Keow J; Chin-Yee B; Hsia CC; Robertson K
    Clin Case Rep; 2023 Dec; 11(12):e8302. PubMed ID: 38111510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
    Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
    J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroesophageal reflux disease accompanying urticaria pigmentosa.
    Reich M; Reich A; Rzeszutko M; Iwańczak B
    Acta Dermatovenerol Croat; 2011; 19(4):264-7. PubMed ID: 22185927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.